Dobutamine: Clinical Trials

5 trials of Dobutamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 recruiting, 1 withdrawn. 5 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 2, Completed 1, Recruiting 1, Withdrawn 1
Phase 24Completed 1, Recruiting 1, Terminated 1, Withdrawn 1

Follow Dobutamine: new trials by email Literature Review of Dobutamine trials Research Report on Dobutamine

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Dobutrex - ATTR Amyloidosis Wild Type
Phase 1 / Phase 2RecruitingSteen Hvitfeldt Poulsen152024-04-082026-06-01
Improving Tissue Oxygenation in Breast Reconstruction Surgery
Dobutamine - Perioperative Tissue Oxygenation
Phase 1 / Phase 2CompletedDr. Glenio Mizubuti (MD, PhD)402019-07-122025-08-05
A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
Albuterol Sulfate, Nicardipine Hydrochloride, Dobutamine Hydrochloride - Drug-Related Side Effects and Adverse Reactions, Cardiovascular System Disease
Phase 1TerminatedCambridge University Hospitals NHS Foundation Trust182017-04-242021-03-22
Dobutamine in the Treatment of Haemodynamic Insufficiency in the Immediate Postnatal Period
Dobutamine - Shock
Phase 1 / Phase 2TerminatedFundacion para la Investigacion Biomedica del Hospital Universitario la Paz152014-05-302017-10-17
Intravenous Allopurinol to Improve Heart Function in Individuals With Dilated Cardiomyopathy
Allopurinol, Dobutamine - Cardiovascular Diseases, Cardiomyopathy, Dilated
Phase 1 / Phase 2WithdrawnUniversity of Pennsylvania2003-06-012013-06-19

Conditions studied

Cardiovascular Diseases (2)  ·  Amyloid Neuropathies, Familial (1)  ·  Cardiomyopathy, Dilated (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Premature Birth (1)  ·  Shock (1)

Sponsors

Cambridge University Hospitals NHS Foundation Trust (1)  ·  Dr. Glenio Mizubuti (MD, PhD) (1)  ·  Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz (1)  ·  Steen Hvitfeldt Poulsen (1)  ·  University of Pennsylvania (1)

Countries

Canada (1)  ·  Denmark (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Adelina Pellicer, MD PhD (1)  ·  Glenio B. Mizubuti, MD, MSc, FRCPC (1)  ·  Heike Rabe, MD PhD (1)  ·  Joseph Cheriyan, MBCHB, MA, FRCP (1)  ·  Thomas P. Cappola (1)

Results publications

PMID 37991835

NIH funding

2023 (1), K23HL071562 (1)